Non-traditional trial designs can help improve the feasibility of biomarker-based screening by accelerating patient recruitment and contributing to cost savings in clinical development.

Nearly 700,000 women will be recruited into an NHS trial of artificial intelligence (AI) tools for breast cancer screening in an attempt to spot the disease earlier and save lives. The EDITH ...

Dr Reddy's And Alvotech Join Hands To Develop Biosimilar For Merck's Blockbuster Cancer Drug FBI Arrests Chinese Researchers For Attempting To Smuggle 'Potential Agroterrorism Weapon' — Kash ...